JPH07147935A - Food for diet-diabetes - Google Patents

Food for diet-diabetes

Info

Publication number
JPH07147935A
JPH07147935A JP5319206A JP31920693A JPH07147935A JP H07147935 A JPH07147935 A JP H07147935A JP 5319206 A JP5319206 A JP 5319206A JP 31920693 A JP31920693 A JP 31920693A JP H07147935 A JPH07147935 A JP H07147935A
Authority
JP
Japan
Prior art keywords
food
rice
water
test
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5319206A
Other languages
Japanese (ja)
Other versions
JP2986324B2 (en
Inventor
Tokutsugu Ota
篤胤 太田
Azusa Taguchi
あずさ 田口
Toshio Takizawa
登志雄 滝沢
Takashi Adachi
堯 足立
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP5319206A priority Critical patent/JP2986324B2/en
Publication of JPH07147935A publication Critical patent/JPH07147935A/en
Application granted granted Critical
Publication of JP2986324B2 publication Critical patent/JP2986324B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE:To obtain the food effective for treating and preventing obesity having a long retention time in the stomach, excellent low-energy palatability, containing a water-soluble food fiber and an insoluble calcium compound. CONSTITUTION:This food for diet.diabetes. contains (A) a water-soluble food fiber (alginic acid or its salt) and (B) an insoluble calcium compound (calcium carbonate or calcium secondary phosphate). When the weight ratio of the component A and B is 1 to >=0.01, the taken food is gelatinized in the stomach and has a long retention time in the stomach. Reduction in intake amount and retardation of absorption of saccharide and lipid can prevent abrupt increase in blood sugar value.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、ダイエット・糖尿病用
食品に関し、詳しくは水溶性食物繊維および不溶性カル
シウム化合物を含有するダイエット・糖尿病用食品に関
する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a diet / diabetes food, and more particularly to a diet / diabetes food containing a water-soluble dietary fiber and an insoluble calcium compound.

【0002】[0002]

【従来の技術と発明が解決しようとする課題】近年、食
生活が豊かになったことに伴い、肥満の増加が大きな問
題となっている。肥満は糖尿病等の各種成人病の原因と
なる場合が多く、美容上も好ましくない。肥満の多くは
エネルギーの過剰摂取が原因であり、有効な予防や治療
の基本となるものは摂取エネルギーを低減することであ
る。しかし、このようなダイエット志向の食事は強い空
腹感を伴うために、これを長期間継続することが難し
く、空腹感をどのように軽減させるかということが大き
な課題である。
2. Description of the Related Art In recent years, an increase in obesity has become a serious problem as dietary habits have become richer. Obesity is often a cause of various adult diseases such as diabetes and is not desirable in terms of beauty. Most obesity is caused by excessive energy intake, and the basis of effective prevention and treatment is to reduce energy intake. However, such a diet-oriented meal is accompanied by a strong feeling of hunger, and it is difficult to continue this for a long period of time, and how to reduce the feeling of hunger is a major issue.

【0003】一方、胃に対する機械的伸展刺激が空腹感
を軽減させることは、経験的に知られており、これを利
用した低エネルギーでかさの多い食物繊維を食品に配合
する方法などが検討されてきた。食物繊維によって空腹
感を軽減するためには、食物繊維が長時間胃に滞留する
ことが必要である。胃内滞留時間はその粘度が高くなる
と共に長くなるが、逆に粘度が高くなると、嗜好性が悪
くなるという問題があった。また、糖尿病の治療におい
ては、患者の耐糖能が低下しているため、通常の食事を
摂取させると、血糖値の急激な上昇をきたす。そのた
め、必要とするエネルギー相当分の食事を何回かに分け
て摂取させたり、少糖類の摂取を制限するなどの食事療
法が行われてきたが、これらの方法は患者や家族にとっ
て大きな負担である。さらに、血糖降下剤などの薬物療
法は副作用の懸念があり、長期間の使用は好ましくな
い。
On the other hand, it is empirically known that mechanical stretch stimulation on the stomach reduces the feeling of hunger, and methods of blending low energy and bulky dietary fiber into foods have been studied. It was In order to reduce the feeling of hunger by dietary fiber, it is necessary for the dietary fiber to stay in the stomach for a long time. The retention time in the stomach becomes longer as the viscosity becomes higher, but conversely, when the viscosity becomes higher, there is a problem that the palatability becomes worse. Further, in the treatment of diabetes, the glucose tolerance of the patient is lowered, and therefore, when a normal diet is taken, the blood glucose level is rapidly increased. For this reason, diets have been performed such as feeding the meal corresponding to the required energy in several divided doses and limiting the intake of oligosaccharides, but these methods are a heavy burden for patients and families. is there. Further, drug therapy such as a hypoglycemic agent may cause side effects and is not preferable for long-term use.

【0004】これらの問題を解決するための技術とし
て、本出願人は先に特開平4−23968号公報に見ら
れるような食品用組成物を完成させた。しかしながら、
先の出願においては、摂取量の低減による体重増加抑制
効果,澱粉等の消化抑制効果,ヒトの耐糖能改善効果等
についての明確な知見が得られていなかった。また、水
溶性食物繊維と不溶性カルシウム化合物の配合比につい
ては、先の出願における配合比率の範囲(1:0.1〜
1:10)では、食品によってはざらつき,味(天然由
来のカルシウム源では不純物等による苦味を生じるもの
がある)等の面から嗜好性が低下する場合があり、また
カルシウム粒子のために見た目が損なわれる場合もあ
り、さらに不必要なカルシウムの多量摂取を避けるため
にも、不溶性カルシウム化合物の配合比率を下げること
が望まれていた。
As a technique for solving these problems, the present applicant has previously completed a food grade composition as disclosed in JP-A-4-23968. However,
In the previous application, no clear knowledge was obtained regarding the effect of suppressing the increase in body weight by reducing the intake, the effect of suppressing the digestion of starch and the like, the effect of improving glucose tolerance in humans, and the like. Regarding the mixing ratio of the water-soluble dietary fiber and the insoluble calcium compound, the range of the mixing ratio in the previous application (1: 0.1-
In 1:10), the palatability may be reduced depending on the food, such as graininess and taste (some naturally-occurring calcium sources cause bitterness due to impurities, etc.), and the appearance may be reduced due to calcium particles. It may be impaired, and it has been desired to reduce the compounding ratio of the insoluble calcium compound in order to avoid unnecessary intake of a large amount of calcium.

【0005】したがって、本発明の第1の目的は、胃内
滞留時間が長く低エネルギー、かつ嗜好性に優れ、しか
も摂取が不足しがちな食物繊維とカルシウムを含有する
肥満の治療または予防に使用されるダイエット用食品を
提供することにある。また、第2の目的は、糖質の消化
を抑制することにより、耐糖能が低下している糖尿病患
者の血糖値の急激な上昇を抑制させる糖尿病用食品を提
供することにある。
Therefore, a first object of the present invention is to use for the treatment or prevention of obesity containing dietary fiber and calcium, which has a long gastric retention time, low energy, excellent palatability, and tends to be insufficiently taken. The purpose is to provide food for diet. A second object is to provide a food for diabetes that suppresses a rapid increase in blood glucose level of a diabetic patient with impaired glucose tolerance by suppressing digestion of sugar.

【0006】[0006]

【課題を解決するための手段】本発明者らは、上記目的
を達成するべく鋭意研究を重ねた結果、所定の水溶性食
物繊維および不溶性カルシウム化合物を食品中に含有さ
せることにより、著しい効果が得られることを見出し、
本発明を完成するに至った。
Means for Solving the Problems As a result of intensive studies to achieve the above object, the present inventors have found that the inclusion of a predetermined water-soluble dietary fiber and an insoluble calcium compound in a food produces a remarkable effect. Find that you can get
The present invention has been completed.

【0007】すなわち、本発明は水溶性食物繊維および
不溶性カルシウム化合物を含有することを特徴とするダ
イエット・糖尿病用食品を提供するものである。
That is, the present invention provides a diet / diabetes food characterized by containing water-soluble dietary fiber and an insoluble calcium compound.

【0008】本発明において水溶性食物繊維としては各
種のものを使用できるが、特にアルギン酸またはその塩
(ナトリウム塩,カリウム塩等)が適している。また、
不溶性カルシウム化合物としては炭酸カルシウム,第2
燐酸カルシウム,卵殻カルシウム,牛骨カルシウム,魚
骨カルシウムなどが好適であり、これらを単独または2
種以上を組合わせて用いることができる。
In the present invention, various kinds of water-soluble dietary fiber can be used, but alginic acid or a salt thereof (sodium salt, potassium salt, etc.) is particularly suitable. Also,
Calcium carbonate as the insoluble calcium compound, second
Calcium phosphate, egg shell calcium, bovine bone calcium, fish bone calcium and the like are preferable, and these are used alone or in combination with 2.
Combinations of more than one species can be used.

【0009】これらのカルシウム化合物は中性領域では
不溶性もしくはほとんど溶解せず、中性の溶液状で該水
溶性食物繊維と混合しても、ゲル化しない。水溶性食物
繊維と不溶性カルシウム化合物の配合量については、重
量比で水溶性食物繊維1に対し、不溶性カルシウム化合
物が0.01以上であれば、本発明の食品が胃液と接触し
た際に、ゲル状となる。しかし、不溶性カルシウム化合
物の割合が0.01未満の場合には、十分なゲル化は起こ
らない。一方、不溶性カルシウム化合物の割合が多すぎ
ても、ざらつき感を生じるため、好ましくない。したが
って、不溶性カルシウム化合物の添加量の上限は通常水
溶性食物繊維1に対し10程度である。
These calcium compounds are insoluble or hardly dissolved in the neutral region, and do not gel even when mixed with the water-soluble dietary fiber in a neutral solution. Regarding the blending amount of the water-soluble dietary fiber and the insoluble calcium compound, if the insoluble calcium compound is 0.01 or more relative to the water-soluble dietary fiber in a weight ratio, when the food of the present invention comes into contact with gastric juice, the gel Become a state. However, when the ratio of the insoluble calcium compound is less than 0.01, sufficient gelation does not occur. On the other hand, if the proportion of the insoluble calcium compound is too large, a rough feeling occurs, which is not preferable. Therefore, the upper limit of the amount of the insoluble calcium compound added is usually about 10 relative to 1 of the water-soluble dietary fiber.

【0010】本発明の食品を摂取すると、胃中でゲル化
することにより、胃での滞留時間が長くなり、空腹感を
軽減することができる。そのため、摂取量が減少し、ま
た糖や脂質の吸収が遅延することにより、体重増加を抑
制することができ、ダイエット用食品として用いること
ができる。その上、本発明の食品を摂取しても、血糖値
の急激な上昇を抑制するため、糖尿病用食品として用い
ることができる。
When the food of the present invention is ingested, it gels in the stomach, so that the residence time in the stomach becomes longer and the feeling of hunger can be reduced. Therefore, the intake is decreased and the absorption of sugar and lipid is delayed, so that the weight increase can be suppressed and the food can be used as a diet food. In addition, even if the food of the present invention is ingested, it can be used as a food for diabetes because it suppresses a sharp rise in blood sugar level.

【0011】本発明の食品は呈味性が低いため、各種の
甘味料,調味料,香辛料等により、その嗜好性を高める
ことができ、各目的に応じ適宜配合することにより、い
かなる食品にも用いることができる。
Since the food of the present invention has a low taste, it is possible to enhance its palatability by using various sweeteners, seasonings, spices and the like. Can be used.

【0012】[0012]

【実施例】以下、実施例を挙げて本発明を具体的に説明
するが、これらは本発明を限定するものではない。 実施例1 成長期ラットを用いた本発明の食品の体重増
加抑制効果 目的 アルギン酸ナトリウムの水溶液は、カルシウムイオンに
よりゲル化する。本実験では餌料中のアルギン酸ナトリ
ウムと第2燐酸カルシウムの含有量の比率を変えてラッ
トに摂取させ、体重増加に及ぼす影響を観察した。
EXAMPLES The present invention will be specifically described below with reference to examples, but these do not limit the present invention. Example 1 Effect of suppressing the weight gain of the food of the present invention using growing rats Objective The aqueous solution of sodium alginate gels with calcium ions. In this experiment, the ratio of the content of sodium alginate to the content of dicalcium phosphate in the feed was changed and the rats were ingested, and the effect on the weight gain was observed.

【0013】方法 1)試験動物 生後4週令のSD系雄性ラット(日本クレア)を用い、
固型飼料(MF、オリエンタル酵母社製)で4日間予備
飼育の後、試験を開始した。試験開始時の体重と血清脂
質濃度をもとに5群(1群6匹)に群分けした。 2)試験飼料,飼育条件 試験飼料は、ラードを脂質源とした高脂肪食とし、各群
毎に以下のようにセルロースパウダーを食物繊維源であ
るアルギン酸ナトリウムに置き換えることにより添加し
た。各群のアルギン酸ナトリウムの量は、0、0.3、
1、3、5%とした(以下、各群を対照、AC0.3%、
AC1%、AC3%、AC5%と記載することがあ
る。)。また、カルシウムは第2燐酸カルシウムを飼料
100g中カルシウム含量520mgの割合で添加し
た。なお、0.3、1、3、5%各群のアルギン酸ナトリ
ウムと第2燐酸カルシウムの重量比は、それぞれ1:5.
8、1:1.75、1:0.58、1:0.35となる。飼料
の組成を表1に示す。
Method 1) Test animal Using 4-week-old male SD rats (CLEA Japan, Inc.),
The test was started after preliminarily breeding for 4 days with solid feed (MF, manufactured by Oriental Yeast Co., Ltd.). Based on the body weight and serum lipid concentration at the start of the test, the animals were divided into 5 groups (6 animals per group). 2) Test feed and breeding conditions The test feed was a high-fat diet using lard as a lipid source, and cellulose powder was added to each group as described below by replacing the cellulose powder with sodium alginate as a dietary fiber source. The amount of sodium alginate in each group was 0, 0.3,
1, 3 and 5% (hereinafter, each group is a control, AC 0.3%,
It may be described as AC1%, AC3%, AC5%. ). As for calcium, dibasic calcium phosphate was added at a ratio of 520 mg of calcium content in 100 g of feed. The weight ratio of sodium alginate and dicalcium phosphate in each group of 0.3, 1, 3, 5% was 1: 5.
8, 1: 1.75, 1: 0.58, 1: 0.35. The composition of the feed is shown in Table 1.

【0014】[0014]

【表1】 [Table 1]

【0015】飼育は室温25℃、12時間の明暗サイク
ル(8:00〜20:00)の飼育室で個別ケージによ
り行い、飼料および飲料水(蒸留水)は、自由摂取とし
た。 3)試験方法 ラットを試験飼料で15日間飼育し、体重と飼料摂取量
を測定した。試験終了時には、15時間絶食の後、エー
テル麻酔下で解剖し、副睾丸脂肪組織と腎周囲脂肪組織
を摘出し、それぞれの重量を測定した。
Breeding was carried out in individual cages in a breeding room with a room temperature of 25 ° C. and a 12-hour light-dark cycle (8:00 to 20:00), and the feed and drinking water (distilled water) were freely ingested. 3) Test method Rats were bred with test feed for 15 days, and the body weight and feed intake were measured. At the end of the test, after fasting for 15 hours, the animals were dissected under ether anesthesia, and epididymal adipose tissue and perirenal adipose tissue were excised and weighed.

【0016】結果 1)体重曲線、体重増加量 図1に示すように、体重は試験飼料摂取開始後のいずれ
の時点でもアルギン酸ナトリウムの含有率の高い群が低
値であり、AC3%、AC5%では、試験飼料開始1日
目から試験終了時まで対照に比し有意(1日目P<0.0
1、2日目以降P<0.001)に低値を示した。さら
に、試験食開始の早い時期には、AC0.3%、AC1%
でも有意(AC0.3%、4日目P<0.05、AC1%2
日目P<0.001、4日目P<0.01、6日目から8日
目P<0.05、絶食時P<0.05)に低値を示した。図
2に示すように、体重増加量においては、15日間の試
験期間を通じて、AC3%、AC5%の群で対照に比
し、有意に低値を示した(P<0.001)。
Results 1) Body weight curve, increase in body weight As shown in FIG. 1, the body weight was low in the group having a high sodium alginate content at any time after the start of ingestion of the test feed, AC3% and AC5%. Then, from the first day of the test feed to the end of the test, it was significant (P <0.0 on the first day)
A low value was shown at P <0.001) from the first and second days. Furthermore, in the early period of the start of the test meal, AC 0.3%, AC 1%
But significant (AC 0.3%, P <0.05 on day 4, AC 1% 2
P <0.001 on day 4, P <0.01 on day 4, P <0.05 on days 6-8, P <0.05 at fasting). As shown in FIG. 2, the weight gain was significantly lower in the AC3% and AC5% groups than in the control over the 15-day test period (P <0.001).

【0017】2)副睾丸脂肪重量、腎周囲脂肪重量 図3,4に示すように、解剖時の脂肪組織重量は、副睾
丸脂肪および腎周囲脂肪共に、総重量,体重100gあ
たりの換算重量のどちらもが、対照に比し、AC3%、
AC5%の群で有意に低値を示した(P<0.001)。
また、AC0.3%、AC1%の群でも有意ではなかった
ものの、低値傾向を示した。 3)飼料摂取量 図5に示すように、15日間の試験期間を通じて、AC
1%、AC3%、AC5%の群で対照に比し有意に低値
を示した(AC1%においてP<0.01、AC3%およ
びAC5%においてP<0.001)。
2) Epididymal Fat Weight, Perirenal Fat Weight As shown in FIGS. 3 and 4, the adipose tissue weight at the time of dissection is the total weight of both epididymal fat and perirenal fat, calculated as the weight per 100 g of body weight. Both have 3% AC compared to the control,
The value was significantly lower in the AC 5% group (P <0.001).
In addition, although the values were not significant in the AC 0.3% and AC 1% groups, the values tended to be low. 3) Feed intake As shown in FIG. 5, AC was used throughout the test period of 15 days.
The values of 1%, 3% AC, and 5% AC were significantly lower than those of the control (P <0.01 in AC1%, P <0.001 in AC3% and AC5%).

【0018】考察 アルギン酸ナトリウムと水不溶性カルシウム化合物の混
合物は、ラットの飼料摂取量を減少させ、体重増加を抑
制する効果があり、飼料中のアルギン酸ナトリウム含量
の上昇に伴い、その効果は強く発現した。また、解剖時
の腎周囲脂肪、副睾丸脂肪重量も低値傾向にあった。こ
のことは摂取された食物の余剰エネルギーが体脂肪とし
て貯蔵されることを抑制しているものと考えられる。以
上の結果より、本発明の食品は肥満に対して有効な食品
であると考える。
Discussion A mixture of sodium alginate and a water-insoluble calcium compound has the effect of reducing the feed intake of rats and suppressing the weight gain, and the effect was strongly expressed as the content of sodium alginate in the feed increased. . Perirenal fat and epididymal fat weight at the time of autopsy also tended to be low. This is considered to suppress the storage of excess energy of the ingested food as body fat. From the above results, it is considered that the food of the present invention is effective against obesity.

【0019】実施例2 本発明の食品の食事性糖および
脂質の吸収遅延に及ぼす影響 目的 本発明の食品の糖および脂質の吸収遅延に及ぼす影響を
実験的に確認するため、糖尿病モデルラットを用い、本
発明の食品を含有する飼料負荷後の血糖値および血中ト
リグリセライドを測定した。
Example 2 Effect of Food of the Present Invention on Delayed Absorption of Dietary Sugars and Lipids Objective In order to experimentally confirm the effect of food of the present invention on delayed absorption of sugars and lipids, diabetic model rats were used. The blood glucose level and blood triglyceride of the food containing the food of the present invention after loading were measured.

【0020】方法 6週令のSD系雄性ラット(日本クレア)にエーテル麻
酔下で頚静脈よりストレプトゾトシン(STZ)をラッ
ト1匹あたり13.3mg(50mg/Kg体重)投与し
た後、2週間予備飼育し、I型糖尿病(IDDM)モデ
ルを作成した。飼育20日目(16時間の絶食の後)に
体重をもとに2群(1群10匹)に分け、1匹あたり5
gの飼料負荷試験を行った。試験飼料は、実施例1で使
用した対照、AC5%の群と同様である。経時的に尾静
脈より採血、血糖値とトリグリセライド値を測定した。
採血時間は飼料負荷直前(0h),飼料負荷3時間後
(3h),5時間後(5h),7時間後(7h),9時
間後(9h)の5時点で行った。飼料は、飼料負荷後3
時間で食べ終えていることを確認した。血糖値およびト
リグリセライドの測定には、それぞれ臨床検査薬(和光
純薬社製)のグルコース CII−テストワコーとトリグ
リセライド E−テストワコーを用い、その測定方法に
基づき分光光度計にて測定した。
Method 6-week-old male SD rats (CLEA Japan, Inc.) were anesthetized with ether and 13.3 mg (50 mg / Kg body weight) of streptozotocin (STZ) was administered to each rat from the jugular vein, followed by preliminary breeding for 2 weeks. Then, a type I diabetes (IDDM) model was created. On day 20 of rearing (after fasting for 16 hours), the animals were divided into 2 groups (10 animals per group) based on their weight, and 5 animals per animal.
The feed load test of g was performed. The test diet is the same as the control used in Example 1, the AC 5% group. Blood was collected from the tail vein over time, and blood glucose and triglyceride levels were measured.
Blood was collected immediately before the feed loading (0 h), 3 hours after the feed loading (3 h), 5 hours after (5 h), 7 hours after (7 h), and 9 hours after (9 h). Feed is 3 after loading
I confirmed that I had finished eating in time. The blood glucose level and triglyceride were measured by using glucose CII-Test Wako and triglyceride E-Test Wako, which are clinical test agents (manufactured by Wako Pure Chemical Industries, Ltd.), and the spectrophotometer was used for the measurement.

【0021】結果 1)血糖値 図6に示すように、対照に比べ、飼料負荷7時間後まで
はいずれの時点でもAC5%では、有意(3h P<0.
05、5h P<0.001、7h P<0.01)に低値
を示した。 2)トリグリセライド 図7に示すように、対照に比べ、AC5%では飼料負荷
後全ての時点において有意(3h, 5h, 7h P<0.
001、9h P<0.05)に低値を示した。
Results 1) Blood glucose level As shown in FIG. 6, as compared to the control, at 5% AC at any time, it was significant (3 h P <0.
05, 5h P <0.001, 7h P <0.01). 2) Triglyceride As shown in FIG. 7, in comparison with the control, at AC5%, significant (3h, 5h, 7h P <0.
001, 9h P <0.05) showed a low value.

【0022】考察 本発明の食品を摂取すると、同時に摂取した糖や脂質を
包み込むとともに、胃内滞留時間を遅延させるため、こ
れらの栄養素の吸収を遅らせることが確認された。ま
た、境界型やII型糖尿病(NIDDM)の初期には、食
後の血糖値の上昇よりインスリンの分泌のパターンが遅
れることがわかっており、糖の吸収が緩やかであれば、
血糖の上昇とインスリンの分泌の時間的なズレを少なく
し、結果的にインスリンの過剰分泌を抑えることができ
る。この作用により本発明の食品は糖尿病の進行を遅延
させることができる。
It has been confirmed that when the food of the present invention is ingested, it simultaneously wraps the ingested sugar and lipid and delays the retention time in the stomach, thus delaying the absorption of these nutrients. In addition, it is known that in the early stages of borderline type and type II diabetes (NIDDM), the pattern of insulin secretion is delayed due to the increase in blood glucose level after eating, and if the absorption of sugar is slow,
It is possible to reduce the time lag between the rise in blood sugar and the secretion of insulin, and consequently suppress the excessive secretion of insulin. Due to this action, the food of the present invention can delay the progression of diabetes.

【0023】実施例3 ボランティアによる本発明の食
品の耐糖能改善作用 目的 本発明の食品の耐糖能改善作用を確認するため、健常人
ボランティアによるアルギン酸ナトリウムとカルシウム
入り飯(以下、A&Caと記載することがある)と、対照
飯のクロスオーバー摂取試験を行い、経時的に血糖値を
測定し、比較した。
Example 3 Glucose Tolerance Improving Action of the Food of the Present Invention by Volunteer Objective To confirm the glucose tolerance improving action of the food of the present invention, sodium and alginate-containing rice by healthy volunteers (hereinafter referred to as A & Ca). , And a crossover intake test of control rice were performed, and blood glucose levels were measured over time and compared.

【0024】方法 1)被験物質の調製 1−1)対照飯の調製 精白米250gをとぎ、ざるにあけ水を切る。水375
g(精白米重量の1.5倍)を加え、30分間浸水後、炊
飯器を用いて炊飯した。炊きあがったご飯の重量を測定
し、精白米100g相当量(糖質換算で75g)でおむ
すび2個を作った。 1−2)A&Ca飯の調製 精白米250gを水洗し、ざるにあけ水を切る。炊飯器
に牛骨カルシウム1.875gを測りとり水10gで懸濁
し、予め調製した1%アルギン酸ナトリウム水溶液37
8.75gを加えて均一に混合した後(アルギン酸ナトリ
ウムとカルシウムの重量比は、1:0.5)、水洗した精
白米を加え30分間浸水させ、通常と同様に炊飯器で炊
飯した。炊きあがったご飯の重量を測定し、精白米10
0g相当量(糖質換算で75g)でおむすび2個を作っ
た。
Method 1) Preparation of test substance 1-1) Preparation of control rice 250 g of polished rice is cut off, drained in a colander and drained. Water 375
g (1.5 times the weight of polished rice) was added, and the rice was soaked for 30 minutes and then cooked with a rice cooker. The weight of the cooked rice was measured, and two rice balls were prepared with 100 g of polished rice (75 g in terms of sugar). 1-2) Preparation of A & Ca rice 250 g of polished rice is washed with water, drained into a colander and drained. Measure 1.875 g of beef bone calcium in a rice cooker and suspend with 10 g of water, and prepare a 1% sodium alginate aqueous solution 37 in advance.
After adding 8.75 g and mixing them uniformly (the weight ratio of sodium alginate and calcium is 1: 0.5), water-washed polished rice was added and water was added for 30 minutes, and then cooked in a rice cooker as usual. The weight of cooked rice is measured and polished rice 10
Two rice balls were made in an amount equivalent to 0 g (75 g in terms of sugar).

【0025】2)被験者 糖代謝に異常を認めない男性1名、女性2名の計3名を
用いた。 3)血糖値の測定 早朝空腹時(12時間以上絶食後)に穿刺採血し、トー
エコーII(小玉製)で血糖値を測定し(0分)、被験物
質(おむすび2個)を摂取させた。摂取30分後と60
分後にも同様な方法で血糖値を測定した。また、一週間
後に同様の方法で、もう一方の被験物を摂取させ血糖値
を測定した。
2) Subjects: A total of 3 persons, 1 male and 2 female, who had no abnormality in glucose metabolism were used. 3) Measurement of blood glucose level A puncture blood was taken at an empty stomach in the early morning (after fasting for 12 hours or more), the blood glucose level was measured by Toecho II (made by Kodama) (0 minutes), and the test substance (two rice balls) was ingested. 30 minutes after ingestion and 60
The blood glucose level was measured by the same method after the minute. Further, one week later, the other test substance was ingested and the blood glucose level was measured by the same method.

【0026】結果 結果を表2および図8に示す。これらに示すように、対
照に比べA&Ca飯を摂取した方が、摂取前に比較し30
分後の血糖値の上昇が抑制された。
Results The results are shown in Table 2 and FIG. As shown in these figures, the intake of A & Ca rice was 30% lower than that of the control.
The increase in blood glucose level after a minute was suppressed.

【0027】[0027]

【表2】 [Table 2]

【0028】考察 本試験においては、個人によって程度の差はあるもの
の、3名ともにA&Ca飯が対照飯に比べ摂取後30分の
血糖値の上昇は抑制されており、消化が緩やかに行われ
ていることが確認された。これらのことより、本発明の
食品は耐糖能改善に有用な食品であることが示唆され
た。
Discussion In this test, although there was a degree of difference depending on the individual, in all three subjects, A & Ca rice was suppressed in the increase in blood glucose level 30 minutes after ingestion compared to the control rice, and digestion was performed slowly. Was confirmed. From these, it was suggested that the food of the present invention is useful for improving glucose tolerance.

【0029】実施例4 ご飯の人工消化試験(その1) サンプル 以下のようにサンプルを調製した。すなわち白米100
gに対し、アルギン酸ナトリウム1.5gを添加し、さら
に各サンプル毎に牛骨カルシウムを以下の通り添加し
た。各サンプルのカッコ内の数値はアルギン酸ナトリウ
ムと牛骨カルシウムとの重量比を示す。 ・A&Ca飯(1:0.5) ;750mg ・A&Ca飯(1:0.1) ;150mg ・A&Ca飯(1:0.05) ; 75mg ・A&Ca飯(1:0.01) ; 15mg ・A&Ca飯(1:0.005); 7.5mg ・A&Ca飯(1:0.001); 1.5mg ・A飯 ; 無添加 ・対照飯 ; 白米のみ
Example 4 Rice artificial digestion test (1) Sample A sample was prepared as follows. That is 100 pieces of white rice
Sodium alginate (1.5 g) was added to g, and bovine bone calcium was added to each sample as follows. The numerical value in the parentheses of each sample indicates the weight ratio of sodium alginate and calcium of bovine bone.・ A & Ca rice (1: 0.5); 750mg ・ A & Ca rice (1: 0.1); 150mg ・ A & Ca rice (1: 0.05); 75mg ・ A & Ca rice (1: 0.01); 15mg ・ A & Ca Rice (1: 0.005); 7.5 mg-A & Ca rice (1: 0.001); 1.5 mg-A rice; no additives-Control rice; only white rice

【0030】試験方法 計量したサンプル(ご飯3g)を口に入れ、15回咀嚼
し、37℃に加温した人工胃液15ml中に投入する。
5分間放置した後、全量を共栓付き三角フラスコに移
し、15mlの0.2Mリン酸Na緩衝液(pH7.0)と
混合する。37℃の恒温槽中で振蕩しながら5分間予備
的に加温の後、ラット小腸由来の消化酵素液1ml(ラ
ット小腸由来の消化酵素 10mg/ml 0.2Mリン
酸Na緩衝液)を加え、人工消化試験を行った。10分
後に200μlをサンプリングし、蒸留水800μlを
加え、沸騰水浴中で5分間加熱し酵素を失活させた。水
冷後、2500rpmで5分間遠心分離し、上清500
μlをサンプリングした。DNS試薬1.5mlを加え、
5分間沸騰水浴中で加熱後水冷し、蒸留水で2倍に希釈
して540nmの分光光度計で澱粉の分解物である二糖
類と単糖類の生成量を測定した。
Test Method A measured sample (3 g of rice) is put into the mouth, chewed 15 times, and put into 15 ml of artificial gastric fluid heated to 37 ° C.
After standing for 5 minutes, the whole amount is transferred to an Erlenmeyer flask with a stopper, and mixed with 15 ml of 0.2 M Na phosphate buffer (pH 7.0). After preliminarily heating for 5 minutes while shaking in a 37 ° C thermostat, 1 ml of digestive enzyme solution derived from rat small intestine (digestive enzyme from rat small intestine 10 mg / ml 0.2M Na phosphate buffer) was added, An artificial digestion test was performed. After 10 minutes, 200 μl was sampled, 800 μl of distilled water was added, and heated in a boiling water bath for 5 minutes to inactivate the enzyme. After cooling with water, centrifuge at 2500 rpm for 5 minutes and the supernatant 500
μl was sampled. Add 1.5 ml of DNS reagent,
After heating in a boiling water bath for 5 minutes, the mixture was cooled with water, diluted twice with distilled water, and the production amounts of disaccharides and monosaccharides, which are decomposition products of starch, were measured with a spectrophotometer at 540 nm.

【0031】結果 結果を図9に示す。図に示すように、対照飯やA飯に比
べA&Ca飯(1:0.01)乃至A&Ca飯(1:0.
5)には明らかな消化抑制効果が見られた。
Results The results are shown in FIG. As shown in the figure, A & Ca rice (1: 0.01) to A & Ca rice (1: 0.
A clear digestive inhibitory effect was observed in 5).

【0032】実施例5 うどんの人工消化試験 サンプル 以下のようにサンプルを調製した。すなわち小麦粉10
0gに対し、アルギン酸ナトリウム3gを添加し、さら
に各サンプル毎に牛骨カルシウムを以下の通り添加し
た。各サンプルのカッコ内の数値はアルギン酸ナトリウ
ムと牛骨カルシウムとの重量比を示す。 ・A&Caうどん(1:0.5) ;1.5g ・Aうどん ; 無添加 ・対照うどん ; 小麦粉のみ
Example 5 Udon Noodle Artificial Digestion Test Sample A sample was prepared as follows. Ie 10 flour
To 0 g, 3 g of sodium alginate was added, and beef bone calcium was added to each sample as follows. The numerical value in the parentheses of each sample indicates the weight ratio of sodium alginate and calcium of bovine bone.・ A & Ca Udon (1: 0.5); 1.5g ・ A Udon; no additives ・ Control Udon; wheat flour only

【0033】試験方法 計量したサンプル(うどん5g)を口に入れ、15回咀
嚼し、37℃に加温した人工胃液15ml中に投入す
る。以下、実施例4と同様に人工消化試験を行った。な
お、測定は経時的(0、5、10、15、20分後)に
行った。 結果 結果を図10に示す。図に示すように、対照うどんやA
うどんに比べA&Caうどん(1:0.5)には明らかな
消化抑制効果が見られた。
Test method A weighed sample (5 g of udon) is put into the mouth, chewed 15 times, and put into 15 ml of artificial gastric fluid heated to 37 ° C. Hereinafter, an artificial digestion test was performed in the same manner as in Example 4. The measurement was carried out over time (0, 5, 10, 15, 20 minutes later). Results Results are shown in FIG. As shown in the figure, contrast udon and A
Compared to udon, A & Ca udon (1: 0.5) had a clear digestive inhibitory effect.

【0034】実施例6 ご飯の人工消化試験(その2) サンプル 以下のようにサンプルを調製した。すなわち白米100
gに対し、アルギン酸ナトリウム1.5gを添加し、さら
に各サンプル毎に牛骨カルシウムを以下の通り添加し
た。各サンプルのカッコ内の数値はアルギン酸ナトリウ
ムと牛骨カルシウムとの重量比を示す。 ・A&Ca飯(1:0.5) ;750mg ・対照飯 ;白米のみ
Example 6 Rice artificial digestion test (Part 2) Sample A sample was prepared as follows. That is 100 pieces of white rice
Sodium alginate (1.5 g) was added to g, and bovine bone calcium was added to each sample as follows. The numerical value in the parentheses of each sample indicates the weight ratio of sodium alginate and calcium of bovine bone.・ A & Ca rice (1: 0.5) 750mg ・ Control rice ; White rice only

【0035】試験方法 実施例4と同様に人工消化試験を行った。ただし、消化
酵素としてα−アミラーゼ(A−6255、Sigma
社製)を0.4ml(50unit/37℃)使用した。
なお、測定は経時的(0、5、10、15、20分後)
に行った。 結果 結果を図11に示す。図に示すように、対照飯に比べA
&Ca飯(1:0.5)には明らかな消化抑制効果が見ら
れた。
Test Method An artificial digestion test was conducted in the same manner as in Example 4. However, α-amylase (A-6255, Sigma) is used as a digestive enzyme.
0.4 ml (50 unit / 37 ° C.) was used.
In addition, the measurement is time-dependent (after 0, 5, 10, 15, 20 minutes)
Went to. Results Results are shown in FIG. As shown in the figure, A
& Ca rice (1: 0.5) showed a clear digestive inhibitory effect.

【0036】[0036]

【発明の効果】本発明の食品を摂取すると、胃中でゲル
化することにより、胃での滞留時間が長くなり、空腹感
を軽減する。そのため、摂取量が減少し、体重増加を抑
制することができる、ダイエットを長期間継続するため
に好適な食品である。また、糖や脂質の吸収が遅延する
ことにより、耐糖能が低下している糖尿病患者の血糖値
の急激な上昇を抑制するため、糖尿病用食品としても好
適である。
EFFECTS OF THE INVENTION When the food of the present invention is ingested, it gels in the stomach, so that the retention time in the stomach becomes longer and the feeling of hunger is reduced. Therefore, it is a food suitable for continuing the diet for a long period of time, which can reduce the intake and suppress the weight gain. Further, it is suitable as a food for diabetes because it suppresses a rapid increase in blood glucose level of a diabetic patient whose glucose tolerance is lowered due to the delayed absorption of sugars and lipids.

【図面の簡単な説明】[Brief description of drawings]

【図1】 ラットの体重の変化を示すグラフである。FIG. 1 is a graph showing changes in body weight of rats.

【図2】 ラットの体重増加量を示すグラフである。FIG. 2 is a graph showing the amount of weight gain in rats.

【図3】 ラットの副睾丸脂肪重量の総重量および体重
100gあたりの換算重量を示すグラフである。
FIG. 3 is a graph showing the total epididymal fat weight of the rat and the converted weight per 100 g of body weight.

【図4】 ラットの腎周囲脂肪重量の総重量および体重
100gあたりの換算重量を示すグラフである。
FIG. 4 is a graph showing the total weight of perirenal fat in rats and the converted weight per 100 g of body weight.

【図5】 ラットの飼料摂取量を示すグラフである。FIG. 5 is a graph showing the feed intake of rats.

【図6】 ラットの血糖値の変化を示すグラフである。FIG. 6 is a graph showing changes in blood glucose level in rats.

【図7】 ラットのトリグリセライドの変化を示すグラ
フである。
FIG. 7 is a graph showing changes in rat triglyceride.

【図8】 ヒトの血糖値の変化を示すグラフであり、A
は被験者No.1, Bは被験者No.2, Cは被験者No.3を示
す。
FIG. 8 is a graph showing changes in blood glucose level in humans.
Indicates subject No. 1, B indicates subject No. 2, and C indicates subject No. 3.

【図9】 ラット小腸由来の消化酵素を用いたご飯の人
工消化試験における消化状態を示すグラフである。
FIG. 9 is a graph showing a digestive state in an artificial digestion test of rice using a digestive enzyme derived from rat small intestine.

【図10】 ラット小腸由来の消化酵素を用いたうどん
の人工消化試験における消化状態の変化を示すグラフで
ある。
FIG. 10 is a graph showing changes in the digestive state in an artificial digestion test for udon using a digestive enzyme derived from rat small intestine.

【図11】 α−アミラーゼを用いたご飯の人工消化試
験における消化状態の変化を示すグラフである。
FIG. 11 is a graph showing changes in the digestive state in an artificial digestion test of rice using α-amylase.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 足立 堯 埼玉県坂戸市千代田5−3−1 明治製菓 株式会社生物科学研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Takashi Adachi 5-3-1 Chiyoda, Sakado City, Saitama Prefecture Meiji Seika Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 水溶性食物繊維および不溶性カルシウム
化合物を含有することを特徴とするダイエット・糖尿病
用食品。
1. A diet / diabetes food, comprising a water-soluble dietary fiber and an insoluble calcium compound.
【請求項2】 水溶性食物繊維が、アルギン酸またはそ
の塩である請求項1記載のダイエット・糖尿病用食品。
2. The food for diet and diabetes according to claim 1, wherein the water-soluble dietary fiber is alginic acid or a salt thereof.
【請求項3】 食品中の水溶性食物繊維と不溶性カルシ
ウム化合物の重量比が、水溶性食物繊維1に対し、不溶
性カルシウム化合物が0.01以上である請求項1記載の
ダイエット・糖尿病用食品。
3. The food for diet and diabetes according to claim 1, wherein the weight ratio of the water-soluble dietary fiber and the insoluble calcium compound in the food is 0.01 or more of the water-soluble dietary fiber and the insoluble calcium compound.
JP5319206A 1993-11-26 1993-11-26 Diet / Diabetic Food Expired - Fee Related JP2986324B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5319206A JP2986324B2 (en) 1993-11-26 1993-11-26 Diet / Diabetic Food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5319206A JP2986324B2 (en) 1993-11-26 1993-11-26 Diet / Diabetic Food

Publications (2)

Publication Number Publication Date
JPH07147935A true JPH07147935A (en) 1995-06-13
JP2986324B2 JP2986324B2 (en) 1999-12-06

Family

ID=18107597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5319206A Expired - Fee Related JP2986324B2 (en) 1993-11-26 1993-11-26 Diet / Diabetic Food

Country Status (1)

Country Link
JP (1) JP2986324B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040315A1 (en) * 1999-11-30 2001-06-07 Dalian Yaweite Biology Engineering Co., Ltd. The alginate having low molecular weight, methods of manufacturing it and its use
JP2002275087A (en) * 2001-03-15 2002-09-25 Mikimoto Pharmaceut Co Ltd Antidiabetic medicine and food for preventing diabetes
WO2002017734A3 (en) * 2000-09-01 2003-04-24 Univ Tennessee Res Corp Materials and methods for the treatment or prevention of obesity
EP1395128A2 (en) 2001-05-31 2004-03-10 Abbott Laboratories Acid controlled viscosity fibre system and uses thereof
US7704979B2 (en) 2000-09-01 2010-04-27 The University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
US7790670B2 (en) 2002-03-01 2010-09-07 Glanbia Nutritionals (Ireland) Ltd. Compositions and methods for treatment of body weight conditions
JP2014000054A (en) * 2012-06-20 2014-01-09 Shimadaya Corp Wheat noodle for preventing rise of blood glucose level after ingestion
US9402858B2 (en) 2009-11-25 2016-08-02 Rd Biomed Limited Inhibition of pancreatic lipase

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001040315A1 (en) * 1999-11-30 2001-06-07 Dalian Yaweite Biology Engineering Co., Ltd. The alginate having low molecular weight, methods of manufacturing it and its use
US7704979B2 (en) 2000-09-01 2010-04-27 The University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
WO2002017734A3 (en) * 2000-09-01 2003-04-24 Univ Tennessee Res Corp Materials and methods for the treatment or prevention of obesity
CN1315409C (en) * 2000-09-01 2007-05-16 田纳西大学研究基金会 Materials and method for the treatment or prevention of obesity
AU2001288707B9 (en) * 2000-09-01 2007-08-30 University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
AU2001288707C1 (en) * 2000-09-01 2008-05-29 University Of Tennessee Research Foundation Materials and methods for the treatment or prevention of obesity
JP2002275087A (en) * 2001-03-15 2002-09-25 Mikimoto Pharmaceut Co Ltd Antidiabetic medicine and food for preventing diabetes
EP1395128A2 (en) 2001-05-31 2004-03-10 Abbott Laboratories Acid controlled viscosity fibre system and uses thereof
EP1395128B2 (en) 2001-05-31 2011-07-13 Abbott Laboratories Acid controlled viscosity fibre system and uses thereof
US8541392B2 (en) 2001-05-31 2013-09-24 Abbott Laboratories Polymer controlled induced viscosity fiber system and uses thereof
US7790670B2 (en) 2002-03-01 2010-09-07 Glanbia Nutritionals (Ireland) Ltd. Compositions and methods for treatment of body weight conditions
US9402858B2 (en) 2009-11-25 2016-08-02 Rd Biomed Limited Inhibition of pancreatic lipase
US9999632B2 (en) 2009-11-25 2018-06-19 Rd Biomed Limited Inhibition of pancreatic lipase
JP2014000054A (en) * 2012-06-20 2014-01-09 Shimadaya Corp Wheat noodle for preventing rise of blood glucose level after ingestion

Also Published As

Publication number Publication date
JP2986324B2 (en) 1999-12-06

Similar Documents

Publication Publication Date Title
Reinhold et al. Effects of purified phytate and phytate-rich bread upon metabolism of zinc, calcium, phosphorus, and nitrogen in man
JPH0124768B2 (en)
JP2002034592A (en) Method for producing protein-zinc readily absorbable in body
JP2986324B2 (en) Diet / Diabetic Food
JP2003113089A (en) Chitosan-containing formulation having action to inhibit lipid accumulation and reduce cholesterol and food and drink
KR20010103065A (en) Diet composition comprising dietary fiber
EP1327443A1 (en) Therapeutic or preventing agent for the diseases caused by a decrease in the expression level of the klotho protein
JP3146086B2 (en) Chicken feed
Herlihy et al. Effects of Aloe vera ingestion in the rat. I. Growth, food and fluid intake and serum chemistry
JP2008184392A (en) Lipid metabolism ameliorator originated from citrus depressa hayata
US20100028457A1 (en) Agent for prevention or treatment of blood glucose level elevation
JP2004189685A (en) Functional composition for oral administration
RU2386365C2 (en) Use of sorbitan derivative to prevent fat absorption
JP3248170B2 (en) Food containing chondroitin sulfate protein complex
JP3336340B2 (en) Rice treated with artificial digestive enzyme and its production method
JP2001515020A (en) Nutrient composition based on dehydrated crab meat
KR102582313B1 (en) Composition for improving joint health by reducing body fat in companion dogs
JP2002080380A (en) Osteogenesis promoter
JPH0912466A (en) Lipid absorption-inhibiting and extrusion-stimulating agent and high fat food
JPH1149682A (en) Oxidized cholesterol adsorbent and its production and adsorption of oxidized cholesterol, and production of food containing cholesterol or oxidized cholesterol
JP2567231B2 (en) Dietary supplement for enhancing endurance
RU2043737C1 (en) Meat-vegetable dietetic and therapeutic food product composition
JPS6368045A (en) Protein composition for food
JPH0376557A (en) Freeze-dried bean curd
RU2098985C1 (en) Bioactive preparation

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071001

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071001

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081001

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091001

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101001

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111001

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111001

Year of fee payment: 12

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111001

Year of fee payment: 12

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121001

Year of fee payment: 13

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131001

Year of fee payment: 14

LAPS Cancellation because of no payment of annual fees